NCT00922181

Single-probe Microwave Ablation (MWA) of Metastatic Liver Cancer

Single-probe Microwave Ablation of Metastatic Liver Cancer is Highly Variable and Irreproducible

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: University Hospital, Gasthuisberg · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Microwave ablation (MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate the variability and reproducibility of single-probe MWA versus radiofrequency ablation (RFA) of metastatic liver tumours smaller than 3 cm in patients without underlying liver disease.

Conditions

• Liver Neoplasms

Interventions

Type	Name	Description
DEVICE	Microwave ablation	Liver tumors are destructed/ablated using single-probe microwave energy device
DEVICE	Radiofrequency ablation	Liver tumors are destructed/ablated using radiofrequency energy device

Timeline

• Start date: 2008-08-01
• Primary completion: 2009-04-01
• Completion: 2009-04-01
• First posted: 2009-06-17
• Last updated: 2009-11-16

Locations

1 site across 1 country: Belgium